# Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients

> **NCT07561541** · PHASE4 · RECRUITING · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 40 (estimated)

## Conditions studied

- Fracture Lower Leg
- Diabetes
- Fracture Fixation, Internal

## Interventions

- **DRUG:** Cefadroxil 500 mg Capsules
- **DRUG:** Clindamycin
- **DRUG:** Bactrim DS

## Key facts

- **NCT ID:** NCT07561541
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07561541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07561541, "Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07561541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*